TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
SEPN

Septerna, Inc.

Healthcare · Biotechnology · —

38.70$ -2.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement SEPN
Line item 2022 2023 2024 2025
100.0% 100.0% 100.0%
3.5%
100.0% 100.0% 100.0%
23,827.2% 6,077.9% 212.4%
6,438.4% 1,540.6% 63.5%
-1,274.2% 7,618.4% 275.8%
1,374.2% -7,518.4% -175.8%
3,225.8% -6,725.2% -106.3%
457.6% -46.3% 0.0%
2,768.2% -6,678.9% -106.4%
-29,604.0% -6,594.9% -102.9%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?